Model
Edge
Five Prime Therapeutics, Inc.
0001518724
Filing Type
4
Filing Date
4/18/2021
Updated
4/19/21, 1:35 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership